Lamivudine and Blood thyroid stimulating hormone decreased - a phase IV clinical study of FDA data

Summary:

Blood thyroid stimulating hormone decreased is reported as a side effect among people who take Lamivudine (lamivudine; zidovudine; nevirapine), especially for people who are male, 40-49 old, have been taking the drug for 6 - 12 months also take Crixivan, and have Tuberculosis.

The phase IV clinical study analyzes which people have Blood thyroid stimulating hormone decreased when taking Lamivudine. It is created by eHealthMe based on reports of 17,197 people who have side effects when taking Lamivudine from the FDA, and is updated regularly.

What is Lamivudine?

Lamivudine has active ingredients of lamivudine; zidovudine; nevirapine. It is often used in hiv infection. eHealthMe is studying from 17,242 Lamivudine users. Check the latest studies of Lamivudine.

What is Blood thyroid stimulating hormone decreased?

Blood thyroid stimulating hormone decreased is found to be associated with 484 drugs and 626 conditions by eHealthMe. Check the latest studies of Blood thyroid stimulating hormone decreased.

On Jul, 12, 2026

17,197 people reported to have side effects when taking Lamivudine.
Among them, 12 people (0.07%) have Blood thyroid stimulating hormone decreased.

Could Lamivudine cause Blood thyroid stimulating hormone decreased?

Among these 12 people:

How long have people been on Lamivudine when they have Blood thyroid stimulating hormone decreased? *

What is the gender of people who have Blood thyroid stimulating hormone decreased when taking Lamivudine? *

female: 36.36 %
male: 63.64 %

What is the age of people who have Blood thyroid stimulating hormone decreased when taking Lamivudine? *

What are other drugs people take besides Lamivudine? *

What are other side effects people have besides Blood thyroid stimulating hormone decreased? *

Nausea (feeling of having an urge to vomit): 5 people, 41.67%
Thyroxine Free Increased: 5 people, 41.67%
Basedow's Disease (autoimmune disease where the thyroid is overactive, producing an excessive amount of thyroid hormones): 4 people, 33.33%
Hyperthyroidism (over activity of the thyroid gland): 4 people, 33.33%
Nausea And Vomiting: 4 people, 33.33%
Weight Decreased: 3 people, 25.00%
Blood Sodium Decreased: 3 people, 25.00%
Haemoglobin Decreased: 3 people, 25.00%
Drug-Induced Liver Injury (diseases of the liver that are caused by physician-prescribed medications): 3 people, 25.00%
Diarrhea: 3 people, 25.00%

What are the existing conditions these people have? *

Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 3 people, 25.00%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Lamivudine and have Blood thyroid stimulating hormone decreased?

- Check whether Blood thyroid stimulating hormone decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lamivudine:

Lamivudine (17,242 reports)

Blood thyroid stimulating hormone decreased treatments and more:

Blood thyroid stimulating hormone decreased (6,536 reports)

How severe was Blood thyroid stimulating hormone decreased and when was it recovered:

Blood thyroid stimulating hormone decreased in Lamivudine

Expand to all the drugs that have ingredients of lamivudine; zidovudine; nevirapine:

Blood thyroid stimulating hormone decreased and drugs with ingredients of lamivudine; zidovudine; nevirapine

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lamivudine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blood thyroid stimulating hormone decreased:

Blood thyroid stimulating hormone decreased (484 drugs)

Browse all the conditions that are associated with Blood thyroid stimulating hormone decreased:

Blood thyroid stimulating hormone decreased (626 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lamivudine; zidovudine; nevirapine (the active ingredients of Lamivudine) and Lamivudine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.